2013 AM Agenda
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Unrestricted Immigration and the Foreign Dominance Of
Unrestricted Immigration and the Foreign Dominance of United States Nobel Prize Winners in Science: Irrefutable Data and Exemplary Family Narratives—Backup Data and Information Andrew A. Beveridge, Queens and Graduate Center CUNY and Social Explorer, Inc. Lynn Caporale, Strategic Scientific Advisor and Author The following slides were presented at the recent meeting of the American Association for the Advancement of Science. This project and paper is an outgrowth of that session, and will combine qualitative data on Nobel Prize Winners family histories along with analyses of the pattern of Nobel Winners. The first set of slides show some of the patterns so far found, and will be augmented for the formal paper. The second set of slides shows some examples of the Nobel families. The authors a developing a systematic data base of Nobel Winners (mainly US), their careers and their family histories. This turned out to be much more challenging than expected, since many winners do not emphasize their family origins in their own biographies or autobiographies or other commentary. Dr. Caporale has reached out to some laureates or their families to elicit that information. We plan to systematically compare the laureates to the population in the US at large, including immigrants and non‐immigrants at various periods. Outline of Presentation • A preliminary examination of the 609 Nobel Prize Winners, 291 of whom were at an American Institution when they received the Nobel in physics, chemistry or physiology and medicine • Will look at patterns of -
書 名 等 発行年 出版社 受賞年 備考 N1 Ueber Das Zustandekommen Der
書 名 等 発行年 出版社 受賞年 備考 Ueber das Zustandekommen der Diphtherie-immunitat und der Tetanus-Immunitat bei thieren / Emil Adolf N1 1890 Georg thieme 1901 von Behring N2 Diphtherie und tetanus immunitaet / Emil Adolf von Behring und Kitasato 19-- [Akitomo Matsuki] 1901 Malarial fever its cause, prevention and treatment containing full details for the use of travellers, University press of N3 1902 1902 sportsmen, soldiers, and residents in malarious places / by Ronald Ross liverpool Ueber die Anwendung von concentrirten chemischen Lichtstrahlen in der Medicin / von Prof. Dr. Niels N4 1899 F.C.W.Vogel 1903 Ryberg Finsen Mit 4 Abbildungen und 2 Tafeln Twenty-five years of objective study of the higher nervous activity (behaviour) of animals / Ivan N5 Petrovitch Pavlov ; translated and edited by W. Horsley Gantt ; with the collaboration of G. Volborth ; and c1928 International Publishing 1904 an introduction by Walter B. Cannon Conditioned reflexes : an investigation of the physiological activity of the cerebral cortex / by Ivan Oxford University N6 1927 1904 Petrovitch Pavlov ; translated and edited by G.V. Anrep Press N7 Die Ätiologie und die Bekämpfung der Tuberkulose / Robert Koch ; eingeleitet von M. Kirchner 1912 J.A.Barth 1905 N8 Neue Darstellung vom histologischen Bau des Centralnervensystems / von Santiago Ramón y Cajal 1893 Veit 1906 Traité des fiévres palustres : avec la description des microbes du paludisme / par Charles Louis Alphonse N9 1884 Octave Doin 1907 Laveran N10 Embryologie des Scorpions / von Ilya Ilyich Mechnikov 1870 Wilhelm Engelmann 1908 Immunität bei Infektionskrankheiten / Ilya Ilyich Mechnikov ; einzig autorisierte übersetzung von Julius N11 1902 Gustav Fischer 1908 Meyer Die experimentelle Chemotherapie der Spirillosen : Syphilis, Rückfallfieber, Hühnerspirillose, Frambösie / N12 1910 J.Springer 1908 von Paul Ehrlich und S. -
Table of Contents (PDF)
June 28, 2016 u vol. 113 u no. 26 From the Cover 7106 Topological defects in liquid crystals E3619 Translation control in Fragile X syndrome E3686 Voltage-sensing phosphatase activities E3782 Aerobic glycolysis and learning 7261 Electric field sensing by bumblebees Contents THIS WEEK IN PNAS Cover image: Pictured is a polarized 7003 In This Issue optical micrograph of a plastic sheet with an array of holes drilled into it and suspended in a nematic-phase liquid LETTERS (ONLINE ONLY) crystal. Lisa Tran et al. found that such a sheet induced arrays of topological E3590 Reduced nitrogen dominated nitrogen deposition in the United States, but its defect lines in a nematic liquid crystal. contribution to nitrogen deposition in China decreased The authors further demonstrated how Xuejun Liu, Wen Xu, Enzai Du, Yuepeng Pan, and Keith Goulding the energy of the liquid crystal and the E3592 Reply to Liu et al.: On the importance of US deposition of nitrogen dioxide, geometry of the holes affect the defect coarse particle nitrate, and organic nitrogen patterns. The findings might have Yi Li, Bret A. Schichtel, John T. Walker, Donna B. Schwede, Xi Chen, Christopher M. B. applications in electronic displays, Lehmann, Melissa A. Puchalski, David A. Gay, and Jeffrey L. Collett Jr. where nematic liquid crystals are widely used. See the article by Tran et al. on E3594 Rise and fall of nitrogen deposition in the United States pages 7106–7111. Image courtesy of Enzai Du Lisa Tran. E3596 Adult pelvic shape change is an evolutionary side effect Philipp Mitteroecker and Barbara Fischer E3597 Reply to Mitteroecker and Fischer: Developmental solutions to the obstetrical dilemma are not Gouldian spandrels Marcia S. -
Die Woche Spezial
In cooperation with DIE WOCHE SPEZIAL >> Autographs>vs.>#NobelSelfie Special >> Big>Data>–>not>a>big>deal,> Edition just>another>tool >> Why>Don’t>Grasshoppers> Catch>Colds? SCIENCE SUMMIT The>64th>Lindau>Nobel>Laureate>Meeting> devoted>to>Physiology>and>Medicine More than 600 young scientists came to Lindau to meet 37 Nobel laureates CAREER WONGSANIT > Women>to>Women: SUPHAKIT > / > Science>and>Family FOTOLIA INFLAMMATION The>Stress>of>Ageing > FLASHPICS > / > MEETINGS > FOTOLIA LAUREATE > CANCER RESEARCH NOBEL > LINDAU > / > J.>Michael>Bishop>and GÄRTNER > FLEMMING > JUAN > / the>Discovery>of>the>first> > CHRISTIAN FOTOLIA Human>Oncogene EDITORIAL IMPRESSUM Chefredakteur: Prof. Dr. Carsten Könneker (v.i.S.d.P.) Dear readers, Redaktionsleiter: Dr. Daniel Lingenhöhl Redaktion: Antje Findeklee, Jan Dönges, Dr. Jan Osterkamp where>else>can>aspiring>young>scientists> Ständige Mitarbeiter: Lars Fischer Art Director Digital: Marc Grove meet>the>best>researchers>of>the>world> Layout: Oliver Gabriel Schlussredaktion: Christina Meyberg (Ltg.), casually,>and>discuss>their>research,>or>their> Sigrid Spies, Katharina Werle Bildredaktion: Alice Krüßmann (Ltg.), Anke Lingg, Gabriela Rabe work>–>or>pressing>global>problems?>Or> Verlag: Spektrum der Wissenschaft Verlagsgesellschaft mbH, Slevogtstraße 3–5, 69126 Heidelberg, Tel. 06221 9126-600, simply>discuss>soccer?>Probably>the>best> Fax 06221 9126-751; Amtsgericht Mannheim, HRB 338114, UStd-Id-Nr. DE147514638 occasion>is>the>annual>Lindau>Nobel>Laure- Geschäftsleitung: Markus Bossle, Thomas Bleck Marketing und Vertrieb: Annette Baumbusch (Ltg.) Leser- und Bestellservice: Helga Emmerich, Sabine Häusser, ate>Meeting>in>the>lovely>Bavarian>town>of> Ute Park, Tel. 06221 9126-743, E-Mail: [email protected] Lindau>on>Lake>Constance. Die Spektrum der Wissenschaft Verlagsgesellschaft mbH ist Kooperati- onspartner des Nationalen Instituts für Wissenschaftskommunikation Daniel>Lingenhöhl> GmbH (NaWik). -
Aaron Ciechanover 2004 Nobel Laureate in Chemistry
TRINITY COLLEGE DUBLIN Medical Research at the Cutting Edge Progress in the fight against Inflammatory Diseases and Cancer Joint Symposium of the Trinity Biomedical Sciences Institute and The Weizmann Institute of Science Tercentenary Hall, Trinity Biomedical Sciences Institute Keynote Speakers July 27-29, 2014 Bruce Beutler 2011 Nobel Laureate in Speakers Physiology and Medicine Opening Address Minister Sean Sherlock TD, University of Texas Minister for Research and Innovation, Irish Government. Aaron Ciechanover Ireland Israel 2004 Nobel Laureate in Chemistry Luke O’Neill Ruth Arnon Technion Israel Institute of TBSI Academic Director The President of the Israel Academy of Technology Diarmuid O’Brien Sciences and Humanities Director of Trinity Research and Mudi Sheves Marc Feldmann Innovation The Weizmann Institute of Science 2003 Albert Lasker Award Andrew Bowie Vice President for Technology Transfer for Clinical Medical Research Trinity Biomedical Sciences Inst. Ido Amit University of Oxford Paul Brown Weizmann Institute of Science England Trinity College Dublin Yinon Ben-Neriah Martin Caffrey Hebrew Univ. of Jerusalem Jules Hoffmann Trinity Biomedical Sciences Inst. 2011 Nobel Laureate in Ashraf Brik Gavin Davey Physiology and Medicine Ben Gurion University Trinity Biomedical Sciences Inst. Institut de Biologie Moleculaire Steffen Jung et Cellulaire, France Aisling Dunne Trinity Biomedical Sciences Inst. Weizmann Institute of Science James Watson Padraic Fallon Eran Elinav 1962 Nobel Laureate in Trinity Biomedical Sciences Inst. Weizmann Institute of Science Physiology and Medicine Alan Irvine Yehuda Kamari Cold Spring Harbor Laboratory Trinity College Dublin Sheba Medical Center New York Vincent Kelly Irit Sagi Trinity Biomedical Sciences Inst. Weizmann Institute of Science Ada Yonath Seamus Martin Idit Shachar 2009 Nobel Laureate in Trinity College Dublin Weizmann Institute of Science Chemistry Kingston Mills David Wallach Weizmann Institute of Science, Trinity Biomedical Sciences Inst. -
2012 Annual Report
Memorial Sloan-Kettering Cancer Center 2012 ANNUAL REPORT A SHARED VISION A SINGULAR MISSION Nurse practitioner Naomi Cazeau, of the Adult Bone Marrow Transplant Service. PING CHI PHYSICIAN-SCIENTIST 10 STEPHEN SOLOMON ALEXANDER RUDENSKY INTERVENTIONAL IMMUNOLOGIST RADIOLOGIST 16 12 VIVIANE TABAR The clinicians and scientists of NEUROSURGEON Memorial Sloan-Kettering share a vision and 18 a singular mission — to conquer cancer. STEPHEN LONG STRUCTURAL BIOLOGIST They are experts united against a 20 SIMON POWELL complex disease. Each type of cancer R ADIATION ONCOLOGIST 24 ETHEL LAW is different, each tumor is unique. Set free NURSE PRACTITIONER in surroundings that invite the sharing of 26 ideas and resources, they attack the CHRISTINA LESLIE complexity of cancer from every angle COMPUTATIONAL BIOLOGIST and every discipline. 34 SCOTT ARMSTRONG PEDIATRIC ONCOLOGIST 30 TO JORGE REIS-FILHO EXPERIMENTAL PATHOLOGIST CONQUER 38 CANCER 04 Letter from the Chairman and the President A complete version of this report — 42 Statistical Profile which includes lists of our donors, 44 Financial Summary doctors, and scientists — 46 Boards of Overseers and Managers is available on our website at 49 The Campaign for Memorial Sloan-Kettering www.mskcc.org/annualreport. 4 5 Letter from the Chairman In 2012 the leadership of Memorial Sloan-Kettering endorsed Douglas A. Warner III These programmatic investments require leadership and and the President a $2.2 billion investment in a clinical expansion that will set vision. Our new Physician-in-Chief, José Baselga, joined the stage for a changing care paradigm into the next decade us on January 1, 2013. An internationally recognized and beyond. -
Nobel Endeavors in Immunology Introducing Dr
SPRING 2012 A PUBLICATION OF SOUTHWESTERN MEDICAL FOUNDATION Nobel Endeavors in Immunology Introducing Dr. Bruce Beutler, UT Southwestern’s fifth Nobel Laureate, and the new Center for the Genetics of Host Defense Southwestern Medical Foundation Board of Trustees 2011-2012 Edward M. Ackerman Joe M. Haggar, III Richard R. Pollock Sara Melnick Albert Nancy S. Halbreich Caren H. Prothro The Heritage Society Rafael M. Anchia LaQuita C. Hall Carolyn Perot Rathjen OF SOUTHWESTERN MEDICAL FOUNDATION Table of Contents Charlotte Jones Anderson Paul W. Harris* Mike Rawlings table of contents Barry G. Andrews Linda W. Hart Jean W. Roach Joyce T. Alban Mr. and Mrs. Thomas E. McCullough Marilyn H. Augur Joe V. (Jody) Hawn, Jr. Linda Robuck Mr. and Mrs. James R. Alexander Christopher F. McGratty Robert D. Rogers Ralph W. Babb, Jr. Jess T. Hay Anonymous (11) Carmen Crews McCracken McMillan Editor Doris L. Bass Frederick B. Hegi, Jr. Catherine M. Rose George A. Atnip# Ferd C. and Carole W. Meyer Nobel Endeavors in Immunology Peter Beck Jeffrey M. Heller* Billy Rosenthal Marilyn Augur* William R. and Anne E. Montgomery Heidi Harris Cannella The threads of Dr. Bruce Beutler’s scientific 3 # Jill C. Bee Julie K. Hersh Lizzie Horchow Routman* Paul M. Bass* Kay Y. Moran career are inextricably woven into the fabric of W. Robert Beavers, M.D. Barbara and Robert Munford Gil J. Besing Thomas O. Hicks Robert B. Rowling* Creative Director UT Southwestern’s history. From intern to mid-career Drs. Paul R. and Robert H. Munger# Jan Hart Black Sally S. Hoglund Stephen H. -
The BBVA Foundation Frontiers of Knowledge Award in Biomedicine Goes to Tony Hunter, Joseph Schlessinger and Charles Sawyers
The BBVA Foundation Frontiers of Knowledge Award in Biomedicine goes to Tony Hunter, Joseph Schlessinger and Charles Sawyers for opening the door to the personalized treatment of cancer The winners represent the three steps in research leading to this advance: Tony Hunter discovered tyrosine kinases, Joseph Schlessinger identified the principle through which they function, and Charles Sawyers brought this knowledge to the clinic and the development of novel cancer therapies Their contributions served initially to treat a variety of leukemia, transforming it from a fatal into a chronic disorder, but have since given rise to effective therapies for lung and breast cancer, melanoma and lymphomas, among other conditions José Baselga, Physician-in-Chief at the Memorial Sloan Kettering Cancer Center in New York and nominator of Charles Sawyers, described the contributions of the three laureates as marking “the birth of personalized anti-cancer medicine” Madrid, January 27, 2015.- The BBVA Foundation Frontiers of Knowledge Award in the Biomedicine category is shared in this seventh edition by Tony Hunter, professor and Director of the Salk Institute Cancer Center in La Jolla, California; Joseph Schlessinger, Chairman of the Department of Pharmacology at Yale University School of Medicine, New Haven, and Charles Sawyers, Human Oncology and Pathogenesis Program Chair at the Memorial Sloan Kettering Cancer Center in New York, for “carving out the path that led to the development of a new class of successful cancer drugs.” For José Baselga, Physician-in-Chief -
Winter 2008/2009
WINTER 2008/09 VOLUME ELEVEN / NUMBER THREE NON-PROFIT U.S. POSTAGE PAID PERMIT 751 SAN DIEGO, CA A PUBLICATION OF THE SCRIPPS RESEARCH INSTITUTE Office of Communications—TPC30 10550 North Torrey Pines Road La Jolla, California 92037 www.scripps.edu PUBLISHER: Keith McKeown EDITOR: Mika Ono DESIGN: Studio 32 North PRODUCTION: Studio 32 North Kevin Fung COVER ILLUSTRATION: Brian Rea INTERIOR ILLUSTRATIONS: Meg Mateo Ilasco PORTRAIT PHOTOGRAPHY: Dana Neibert PRINTING: Precision Litho Copyright © 2008. Published by TSRI Press™ “I benefited tremendously from the truly interdisciplinary nature of the Skaggs Institute.” THE SCRIPPS RESEARCH INSTITUTE EXPERTS IN ALMOST JIANMIN GAO, Ph.D. EVERY SUBFIELD JIANMIN GAO, Ph.D. (top) Jianmin Gao, Ph.D., now an assistant professor of chem- exchange ideas, which greatly broadens the horizon of PER HAMMARSTROM, istry at Boston College, served as a postdoctoral fellow scientific problems one dares to tackle.” Ph.D. at the Skaggs Institute under Jeffery Kelly, Ph.D., chair At Boston College, Gao is working on protein folding (bottom) VOLUME ELEVEN / NUMBER THREE WINTER 2008/09 of the Department of Molecular and Experimental Medi- and aggregation, specifically on the folding mechanisms cine and Lita Annenberg Hazen Professor of Chemistry. of beta-structured membrane proteins, which play vital Kelly is also chair of the Board of Trustees of the Skaggs roles in cancer biology. Gao strives to use chemical tools Institute for Research, one of the Skaggs family’s major to bring a fresh look at biological problems. mechanisms for its philanthropy. Understanding the chemistry and biology of mem- 41 “I benefited tremendously from the truly interdisci- brane protein folding is a substantial challenge, and plinary nature of the Skaggs Institute,” said Gao. -
100Th RAF Raffle – Kurt Durlesser and Evan Garcia OHRPP Updates
Marcia L. Smith November 14, 2019 2 Welcome & Announcements 2009 - 2019 3 4 Agenda • Office of the Human Research Protection Program ◦ Roll-out of PI and Faculty Assurances – Moore Rhys • Extramural Fund Management ◦ Closing Expired Funds – Will Murdoch ◦ ERS Listserv Changes – Will Murdoch ◦ Ascend: Expenditure Type – Yoon Lee • UCLA Trivia and 100th RAF Raffle – Kurt Durlesser and Evan Garcia OHRPP Updates November 14, 2019 – 100th RAF 2 OHRPP Updates Annual PI and FS Assurances Human Research News Training opportunities 3 Annual PI and Faculty Sponsor Assurances In order to keep track of active studies that don’t require continuing review, OHRPP has worked with ORIS to create a mechanism for a yearly check-in with investigators. 4 Annual PI and Faculty Sponsor Assurances These will be required (in lieu of continuing review) to continue the following types of research: • Certified exempt • Studies determined eligible for expedited review • Research that has progressed to the point of only collecting results of clinical care procedures/tests for follow-up • Research that has progressed to the point of data analysis only • Studies where a UCLA IRB is relying on another IRB 5 Annual PI and Faculty Sponsor Assurances Automatic email notices (with instructions) will be sent out from the webIRB system: - 9 months after the initial approval (or last annual assurance) – 3 months before the assurance is due - 10 months after the initial approval (or last annual assurance) – 2 months before the assurance is due - 11 months after the initial approval (or last annual assurance – 1 month before the assurance is due - 12 months after the initial approval (or last annual assurance) – the day the assurance is due 6 Annual PI and Faculty Sponsor Assurances Important: If the PI (and faculty sponsor, if applicable) doesn’t complete the annual assurance, the study will be administratively closed PI proxies cannot complete the assurance 7 Annual PI and Faculty Sponsor Assurances If the PI has a faculty sponsor, the faculty advisor must complete their assurance first. -
Lasker Awards Honor Trailblazers in Medical Research and Public Service
EMBARGOED FOR RELEASE UNTIL SEPTEMBER 14, 2009 FROM: The Albert and Mary Lasker Foundation New York, New York CONTACT: Rubenstein Communications, Inc. Charles Zehren 212-843-8590 [email protected] Janet Wootten 212-843-8032 [email protected] 2009 LASKER AWARDS HONOR TRAILBLAZERS IN MEDICAL RESEARCH AND PUBLIC SERVICE: John Gurdon and Shinya Yamanaka, for Breakthrough Research in Nuclear Reprogramming and Stem Cells Brian J. Druker, Nicholas B. Lydon and Charles L. Sawyers, for Lifesaving Discoveries in Treatment of Leukemia Michael R. Bloomberg, for Landmark Policy and Philanthropic Initiatives to Reduce Tobacco Use and Foster Public Health New York, Sept. 13, 2009 - The Albert and Mary Lasker Foundation, which for 64 years has championed the greatest breakthroughs in medical research, today announced the winners of the 2009 Lasker Awards for outstanding accomplishments in basic medical and clinical medical research, and public service. The three awards—recognized as the most prestigious medical research awards in the United States today— honor six visionaries whose insight and courage has led to dramatic advances that will prevent disease and prolong life. John Gurdon of Cambridge University and Shinya Yamanaka of Kyoto University will receive the 2009 Albert Lasker Basic Medical Research Award for breakthrough discoveries into the process that instructs specialized adult cells to form stem cells. Brian J. Druker of Oregon Health & Science University, Nicholas B. Lydon, formerly of Novartis, and Charles L. Sawyers of Memorial Sloan-Kettering Cancer Center will receive the 2009 Lasker~DeBakey Clinical Medical Research Award for groundbreaking work on the treatment of chronic myeloid leukemia. New York City Mayor Michael R. -
LLS AR 2005.Pdf
LEUKEMIA LYMPHOMA MYELOMA 2005 Annual Report our mission Cure leukemia, Over its history, the Society has been the recognized leader in the fight against leukemia. Our name change to The Leukemia & Lymphoma lymphoma, Society in 2000 was simply perception catching up to reality. The Hodgkin’s Society’s objective is to find cures for all blood cancers, and to be disease and the leading resource for patients battling all of these cancers. myeloma, and This year, the Society took the first step in making access to specific improve the information and services simpler for patients with these cancers. quality of life We developed a color-coding system for the three main categories of blood cancers: Our new signature colors are green for leukemia, of patients and gold for lymphoma and blue for myeloma. Any information that their families. is relevant to all the diseases is coded burgundy. All print materials prepared for patients during this year reflect the new system, making access to important information and resources more efficient. You’ll also see our new colors in such e-newsletters as LeukemiaLinks, LymphomaLinks and MyelomaLinks. The next step will be to extend the new system to other venues, including access to information on the Society’s Web site. This year’s Annual Report displays the new colors with pride. They represent the ongoing efforts to constantly improve on the ways the Society serves and supports patients and those who love and 2 005 | care for them. AN N U AL R EPOR T leadership message We are fortunate to be able to report that fiscal year 2005 was a banner year for the Society in many ways.